Taiwan Biomaterial Co., Ltd.
6649
Rank in Stocks
#23081
Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan,... Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan, focuses on the innovation, development, and commercialization of medical devices throughout Taiwan. Their product offerings include Foamagen, a pioneering dural substitute characterized by its foamy structure. The company also provides a sophisticated negative pressure catheter system engineered for stroke intervention, which efficiently suctions and removes cerebrovascular embolism blood clots, accompanied by a specialized nickel-titanium guidewire essential for guiding intricate neurovascular procedures. Additionally, Taiwan Biomaterial develops advanced tissue repair and regeneration solutions specifically targeting the treatment of early-stage osteoarthritis.
Share Price
$1.09
Last synced: 2026-11-09
Market Cap
$45.96M
Change (1 day)
5.08%
Change (1 year)
-32.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiwan Biomaterial Co., Ltd. (6649)
Category
Healthcare
Operating Margin for Taiwan Biomaterial Co., Ltd. (6649)
Operating Margin as of November 2026 TTM: 10.12%
According to Taiwan Biomaterial Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 10.12%. At the end of 2025 the company had an operating margin of 27.60%.
Operating Margin history for Taiwan Biomaterial Co., Ltd. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 10.12% | -63.33% |
| 2025 | 27.60% | -337.32% |
| 2024 | -11.63% | -40.45% |
| 2023 | -19.53% | -197.65% |
| 2022 | 20.00% | -114.70% |
| 2021 | -136.10% | -62.22% |
| 2020 | -360.22% | -18.43% |
| 2019 | -441.59% | -93.47% |
| 2018 | -6,764.14% | 139.78% |
| 2017 | -2,820.97% | 60.97% |
| 2016 | -1,752.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -98.49% |
US
|
|
| 18.08% | -98.21% |
IE
|
|
| 21.25% | -97.90% |
US
|
|
| 21.05% | -97.92% |
US
|
|
| 28.09% | -97.22% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Taiwan Biomaterial Co., Ltd.'s operating margin
What is Taiwan Biomaterial Co., Ltd.'s operating margin?
Taiwan Biomaterial Co., Ltd.'s operating margin is 10.12%, as of Nov 2026.
What was Taiwan Biomaterial Co., Ltd.'s operating margin in 2025?
In 2025, Taiwan Biomaterial Co., Ltd.'s operating margin was 27.60%, compared with -11.63% in 2024.
How has Taiwan Biomaterial Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Taiwan Biomaterial Co., Ltd.'s operating margin was highest in 2025 (27.60%) and lowest in 2020 (-360.22%).
How does Taiwan Biomaterial Co., Ltd.'s operating margin compare with similar companies?
Taiwan Biomaterial Co., Ltd.'s operating margin (10.12%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.